Susan Hasty, Publisher
Table of Contents . . . March 4th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Transmission - Cytotoxic T-cell activity crucial for persistently uninfected women
AIDS and HIV Vaccine - Multiantigen vaccine with recombinant gp160 effective in newly infected patients
AIDS and HIV Pathogenesis - Substance P may aid viral replication
AIDS and HIV Therapy - Antiretroviral therapy lowers coagulation-related activity
AIDS and HIV Therapy - Hydroxyurea effective against infected dendritic cells
AIDS and HIV Therapy - Monocytes can act as viral reservoir in HAART patients
Coinfection - Interleukin-2 useful for treating those coinfected with HIV, hepatitis C
AIDS Therapies - New one-tablet, once-daily formulation of Sustiva approved
AIDS Therapy - Vietnam plans to produce cheap AIDS drugs
AIDS Vaccine - Berna Biotech teams with IAVI, Gallo lab, Uganda for test
AIDS Vaccines - Epimmune provides HIV vaccine program update
AIDS Vaccines - GlaxoSmithKline Biologicals announces start of human trial of novel HIV vaccine
AIDS and HIV Therapy - Neomycin B-arganine conjugate shows promise
Appointments - Regulatory affairs, QA personnel hired
Developing Nations - Lack of health workers imperils Africa's gains, UN agency warns
Epidemiology - Efforts to prevent perinatal HIV transmission in Michigan highly successful
Funding - Gates, Bono call on leaders at World Economic Forum to increase health spending
HIV Prevention - GlaxoSmithKline starts human clinical trial of HIV vaccine
HIV-associated Nephropathy - Phase II trial of KRX-101 initiated
Hemophilia - Smallpox vaccinations may pose health risk for people with HIV
Infectious Disease - CEOs call for freater corporate engagement against HIV/AIDS, TB, malaria
Policy - FAO conference hears that AIDS compounds hunger problems in Africa
Policy - Young South African doctors protest government's position on AIDS drugs
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.